Deals
The startup has raised $30m so far.
1
SG's Ropedia bags $22m pre-Series A to scale data infra for physical AI
2
GIC stress-tests portfolio for climate risks, invests in untapped adaptation set
3
India: Temasek-backed Manipal Health seeks $8b valuation in IPO
4
Beyond the Buyout: Red-hot HK markets drive HKIC numbers
5
GIC reports lower return on portfolio, identifies AI as key investment focus
More Stories
Singapore’s Monk’s Hill undergoes restructuring, strategy shift
Indonesia taps Hong Kong’s IPO revival as dual-listing pipeline gathers pace
HK’s ZQ Capital closes $300m fund backed by $35m internal commitment
Allianz to acquire HSBC’s Singapore insurance business in $2b deal
Consumer-focused BA Capital closes second USD fund at $225m
Climate Tech & ESG
It expects investment in climate adaptation to grow.
IPOs & Markets
The company is looking to raise $960 million in the IPO.
Analysis
HKIC has a portfolio of over 200 firms. So far, 10 have listed in HK, with 30 more in the pipeline.
Earnings and Results
It is also refreshing its investment framework from this year to leverage its capabilities in active investing.
Singapore
Investors’ changing approach to AI is evident in the questions asked during due diligence.
India
The company specialises in kidney care services, including nephrology, urology, and renal transplantation.
They will be allowed to invest in overseas securities, bringing them in line with MFs and AIFs.
They argued that it could entrench the dominance of the bigger payment apps.
Greater China
The debut will spotlight China’s state-led push to turn public capital into technology champions.
